Nemluvio is now the first approved monoclonal antibody that specifically targets interleukin-31 receptor alpha ...

The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations ...

Approval of Onapgo (apomorphine hydrochloride) marks the first and only subcutaneous apomorphine infusion device for managing motor fluctuations in adults with advanced Parkinson disease.

Onapgo is the first and only wearable subcutaneous apomorphine infusion ... included infusion-site nodule, nausea, excessive sleepiness, infusion-site skin irritation, headache, and insomnia.

Seven had renal involvement (biopsy proven in three), three had lung nodules and one had retro ... treated with subcutaneous EPO-α, in whom neutralizing anti-EPO antibodies developed after ...

2,6 The physical examination should include assessment of the clinical morphology of the subcutaneous nodules. Knuckle pads are challenging to diagnose based on a physical examination alone because ...

Glomus tumours are uncommon, benign neoplasms originating from the glomus body, predominantly affecting adults between 20–40 ...

Bengaluru: Bharat Biotech group company Biovet, an innovative animal health vaccine producer based in Mallur, Karnataka, has ...